Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[Actual state of ex vivo chemoresistance testing of malignant tumors in Masaryk Memorial Cancer Institute Brno].

Poprach A, Michalová E, Pavlík T, Lakomy R, Vyskocil J, Nemeccek R, Zaloudík J, Vyzula R, Kocák I, Kocáková I.

Klin Onkol. 2008;21(3):116-21. Czech.

PMID:
19097421
3.

[Chemoresistance/Chemosensitivity of ovarian cancer--a case report].

Sedláková I, Tosner J, Rezác A, Cervinka M, Tomsová M, Spacek J.

Ceska Gynekol. 2008 Jun;73(3):140-3. Czech.

PMID:
18646664
4.

Chemosensitivity and chemoresistance testing in ovarian cancer.

Cree IA.

Curr Opin Obstet Gynecol. 2009 Feb;21(1):39-43. doi: 10.1097/GCO.0b013e32832210ff. Review.

PMID:
19125002
5.

[Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].

Lakomý R', Greplová K, Pilný R, Budinská E, Valík D, Poprach A, Nemecek R, Vyzula R.

Klin Onkol. 2009;22(5):228-32. Czech.

PMID:
19886361
6.

Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.

Neale MH, Myatt NE, Khoury GG, Weaver P, Lamont A, Hungerford JL, Kurbacher CM, Hall P, Corrie PG, Cree IA.

Melanoma Res. 2001 Dec;11(6):601-9.

PMID:
11725206
7.

In vitro chemosensitivity of human soft tissue sarcoma.

Morioka H, Yabe H, Morii T, Yamada R, Kato S, Yuasa S, Yano T.

Anticancer Res. 2001 Nov-Dec;21(6A):4147-51.

PMID:
11911309
8.

[Results of antineoplastic chemotherapy based on the oncobiogram].

Ebert A, Lenk H, Geyer J, Tanneberger S.

Arch Geschwulstforsch. 1989;59(6):455-61. German.

PMID:
2596959
9.

Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic.

Fridborg H, Jonsson E, Nygren P, Larsson R.

Eur J Cancer. 1999 Mar;35(3):424-32.

PMID:
10448294
10.

In vitro chemosensitivity testing and mechanisms of drug resistance.

Tewari K, Manetta A.

Curr Oncol Rep. 1999 Sep;1(1):77-84. Review.

PMID:
11122802
11.

Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.

Kurbacher CM, Cree IA.

Methods Mol Med. 2005;110:101-20. Review.

PMID:
15901931
12.

[Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method].

Michalová E, Poprach A, Nemecková I, Nenutil R, Valík D, Zaloudík J, Vyzula R, Vojtesek B.

Klin Onkol. 2008;21(3):93-7. Review. Czech.

PMID:
19097417
13.
14.
15.

Ex vivo enrichment of malignant carcinoma cells in primary culture.

Heinzman JM, Brower SL, Bush JE, Silverman JF.

Pathology. 2007 Oct;39(5):491-4.

PMID:
17886099
16.

Chemosensitivity and chemoresistance testing.

Markman M.

J Clin Oncol. 2005 Oct 10;23(29):7363-4. No abstract available.

17.
18.

Tumor chemosensitivity and chemoresistance assays.

Brown E, Markman M.

Cancer. 1996 Mar 15;77(6):1020-5. Review.

19.

Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.

Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.

Am J Surg Pathol. 2009 Aug;33(8):1125-36. doi: 10.1097/PAS.0b013e31819e986a.

PMID:
19440148
20.

In vitro chemoresistance testing in well-differentiated carcinoid tumors.

Lyons JM 3rd, Abergel J, Thomson JL, Anthony CT, Wang YZ, Anthony LB, Boudreaux JP, Strauchen J, Idrees M, Warner RR, Woltering EA.

Ann Surg Oncol. 2009 Mar;16(3):649-55. doi: 10.1245/s10434-008-0261-z. Epub 2009 Jan 8.

PMID:
19130141
Items per page

Supplemental Content

Write to the Help Desk